A detailed history of M28 Capital Management LP transactions in Pro Qr Therapeutics N.V. stock. As of the latest transaction made, M28 Capital Management LP holds 1,019,498 shares of PRQR stock, worth $2.72 Million. This represents 1.76% of its overall portfolio holdings.

Number of Shares
1,019,498
Previous 1,019,498 -0.0%
Holding current value
$2.72 Million
Previous $1.69 Million 9.63%
% of portfolio
1.76%
Previous 1.95%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$1.89 - $2.85 $1.68 Million - $2.54 Million
-891,102 Reduced 46.64%
1,019,498 $2.33 Million
Q4 2022

Feb 10, 2023

BUY
$0.8 - $3.7 $727,040 - $3.36 Million
908,800 Added 90.72%
1,910,600 $7.07 Million
Q1 2022

May 13, 2022

BUY
$0.9 - $8.39 $901,620 - $8.41 Million
1,001,800 New
1,001,800 $907,000

Others Institutions Holding PRQR

About ProQR Therapeutics N.V.


  • Ticker PRQR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,362,096
  • Market Cap $191M
  • Description
  • ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...
More about PRQR
Track This Portfolio

Track M28 Capital Management LP Portfolio

Follow M28 Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M28 Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on M28 Capital Management LP with notifications on news.